Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial

MLA

Silvia Lanfranconi, et al. “Propranolol for Familial Cerebral Cavernous Malformation (Treat_CCM): Study Protocol for a Randomized Controlled Pilot Trial.” Trials, vol. 21, no. 1, May 2020, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13063-020-4202-x.

APA

Silvia Lanfranconi, Elisa Scola, Giulio Andrea Bertani, Barbara Zarino, Roberto Pallini, Giorgio d’Alessandris, Emanuela Mazzon, Silvia Marino, Maria Rita Carriero, Emma Scelzo, Giuseppe Faragò, Marco Castori, Carmela Fusco, Antonio Petracca, Leonardo d’Agruma, Laura Tassi, Piergiorgio d’Orio, Maria Grazia Lampugnani, Enrico Bjorn Nicolis, … the Treat-CCM Investigators. (2020). Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial. Trials, 21(1), 1–10. https://doi.org/10.1186/s13063-020-4202-x

Chicago

Silvia Lanfranconi, Elisa Scola, Giulio Andrea Bertani, Barbara Zarino, Roberto Pallini, Giorgio d’Alessandris, Emanuela Mazzon, et al. 2020. “Propranolol for Familial Cerebral Cavernous Malformation (Treat_CCM): Study Protocol for a Randomized Controlled Pilot Trial.” Trials 21 (1): 1–10. doi:10.1186/s13063-020-4202-x.